Abstract:Objective To compare the efficacy and toxicity of vinorelbine plus cisplatin(NP) and paclita-xel plus cisplatin(TP) combinations in the treatment of advanced non-small-cell lung cancer(NSCLC) .Methods From December 1997 to April 2002, a total of 59 patients with advanced NSCLC were randomized to receive vinorelbine 25 mg/m2 on days 1,8 by twenty-minute infusion and cisplatin 45 mg/m2 on day 1 (group NP) , or paclita-xel 135 mg/m2 by 3-hour infusion and cisplatin 80 mg/m2 on day 1(group TP). Both regimens were repeated every 3 weeks. Results A total of 59 patients (30 patients in group TP, 29 patients in group TP) were enrolled. All characteristics were well matched between the two groups. In total, 188 cycles of NP and 93 cycles of TP were given. The median duration of response was 5.5 months for group NP and 4.5 months for group TP.The overall response rate for group NP was 46.7% , with 6.6% complete response(CR) ,40.0% partial response(PR) ,40.0% stable disease(SD) and 13. 3% progression of disease(PD), and in group TP, the overall response rate was 44. 8% (3.4% CR,41.4% PR,37.9% SD,and 17.2% PD)(P0.75).The response rate was higher in grade Ⅲb cases than in grade Ⅳ cases(77.8% vs 33.3% in group NP,P = 0.0288,and 85.7% vs 31.8% in group TP, P = 0.0176),higher in previously untreated cases than in treated cases(72.7% vs 31.6% in group NP, P = 0.0308,and 75.0% vs 33.3% in group TP, P = 0.0480).The incidence of neutropenia and thrombocytopenia were 66.7% and 51.7% in group NP,and 33.3% and 31.0% in group TP,respectively.Phlebitis(63.3% vs 3.4%)and nausea/vomiting(55.3% vs 41.4%)were more severe in group NP.By contrast,alopecia(93.1% vs 23.3%)and peripheral neurotoxicity/myalgia(72.4% vs 36.7%)were more frequent in group TP.The frequency and severity of other toxic reactions were comparable between the two groups. No WHO grade Ⅳ toxicity occurred. Conclusion Both NP and TP combined chemotherapy produce similar efficacy and are well tolerated in patients with advanced non-small-cell lung cancer.

A Clinical Comparison of Tetrahydropyranyl Adriamycin Vs. Adriamycin in the Treatment of Non-Hodgkin's Lymphoma

Adriamycin containing regimens in treating 40 cases of non-Hodgkin's lymphoma

The Clinical Efficacy of All-Trans Retinoic Acid Plus Arsenic Trioxide in 177 Newly Diagnosed Acute Promyelocytic Leukemia Patients

Clinical Trial in the Treatment of Non-Hodgkin's Lymphoma's with Escalated CTOP Regimen

[Treatment Outcome Analysis of CTOP or CHOP Regimen in Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Patients-Results of a Prospective, Open, Randomized, Multicenter Clinical Trial].

Comparable Efficacy and Less Toxicity of Pegylated Liposomal Doxorubicin Versus Epirubicin for Neoadjuvant Chemotherapy of Breast Cancer: a Case-Control Study

A Comparison of High Dose Epirubicin in Single Administration and Multiple Administrations in CHOP Regimen for 72 Cases with Non-Hodgkin's Lymphoma(NHL)

Five-year Survival Analysis of Patients with Non-Hodgkin's Lymphoma Treated with Escalated CTOP Regimen

Comparison of Cisplatin-Mitomycin-vinorelbine Versus Cisplatin-Mitomycin-vindesine Regimen for Treatment of Advanced Non-Small Cell Lung Cancer: a Report of 83 Patients

Comparison of the efficacy and safety of standard and reduced doses of dexamethasone combined with bortezomib and adriamycin in the treatment of patients with multiple myeloma

Comparison of Pharmacokinetics, Efficacy and Toxicity Profile of Gemcitabine Using Two Different Administration Regimens in Chinese Patients with Non-Small-cell Lung Cancer

Clinical Study of Paclitaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Treatment of Patients with Advanced Non-Small-cell Lung Cancer

Comparison of NP Regimen and TP Regimen in Treatment of Advanced Breast Cancer

Comparison of Homoharringtonine and Daunorubicin Cardiotoxicity in Adults with Acute Promyelocytic Leukemia

Comparisons of two chemoradiotherapy regimens for locally advanced non-squamous and non-small cell lung cancer

A Retrospective Study to Compare the Use of Tacrolimus and Cyclosporine in Combination with Adriamycin in Post-Transplant Liver Cancer Patients

Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma

A Meta-analysis of Platinum Plus Taxanes Regimen on Treating Advanced Non-small Cell Lung Cancer

Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China

Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma